Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Income from Continuing Operations (2021 - 2025)

Historic Income from Continuing Operations for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to -$3.4 million.

  • Tenon Medical's Income from Continuing Operations fell 550.54% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year increase of 497.64%. This contributed to the annual value of -$13.8 million for FY2024, which is 1236.98% up from last year.
  • Tenon Medical's Income from Continuing Operations amounted to -$3.4 million in Q3 2025, which was down 550.54% from -$2.9 million recorded in Q2 2025.
  • Tenon Medical's 5-year Income from Continuing Operations high stood at -$200000.0 for Q1 2021, and its period low was -$7.9 million during Q4 2022.
  • In the last 5 years, Tenon Medical's Income from Continuing Operations had a median value of -$3.3 million in 2022 and averaged -$3.5 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first tumbled by 107650.0% in 2022, then surged by 6012.63% in 2023.
  • Over the past 5 years, Tenon Medical's Income from Continuing Operations (Quarter) stood at -$2.8 million in 2021, then plummeted by 178.58% to -$7.9 million in 2022, then skyrocketed by 60.13% to -$3.2 million in 2023, then fell by 0.47% to -$3.2 million in 2024, then fell by 6.9% to -$3.4 million in 2025.
  • Its Income from Continuing Operations stands at -$3.4 million for Q3 2025, versus -$2.9 million for Q2 2025 and -$3.7 million for Q1 2025.